BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21907336)

  • 1. The use of dual-phase 18F-FDG PET in characterizing thyroid incidentalomas.
    Hsiao YC; Wu PS; Chiu NT; Yao WJ; Lee BF; Peng SL
    Clin Radiol; 2011 Dec; 66(12):1197-202. PubMed ID: 21907336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization.
    Choi JY; Lee KS; Kim HJ; Shim YM; Kwon OJ; Park K; Baek CH; Chung JH; Lee KH; Kim BT
    J Nucl Med; 2006 Apr; 47(4):609-15. PubMed ID: 16595494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-phase 18F-FDG PET in the diagnosis of pulmonary nodules with an initial standard uptake value less than 2.5.
    Chen CJ; Lee BF; Yao WJ; Cheng L; Wu PS; Chu CL; Chiu NT
    AJR Am J Roentgenol; 2008 Aug; 191(2):475-9. PubMed ID: 18647920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid incidentalomas detected on 18F-fluorodeoxyglucose-positron emission tomography/computed tomography: Thyroid Imaging Reporting and Data System (TIRADS) in the diagnosis and management of patients.
    Yoon JH; Cho A; Lee HS; Kim EK; Moon HJ; Kwak JY
    Surgery; 2015 Nov; 158(5):1314-22. PubMed ID: 25958065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation.
    Kim BH; Na MA; Kim IJ; Kim SJ; Kim YK
    Ann Nucl Med; 2010 Dec; 24(10):721-8. PubMed ID: 20830537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of solitary thyroid nodule on 18F-FDG PET/CT and high-resolution ultrasonography.
    D'Souza MM; Marwaha RK; Sharma R; Jaimini A; Thomas S; Singh D; Jain M; Bhalla PJ; Tripathi M; Tiwari A; Mishra A; Mondal A; Tripathi RP
    Ann Nucl Med; 2010 Jun; 24(5):345-55. PubMed ID: 20373060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid incidentalomas identified by 18F-FDG PET: sonographic correlation.
    Kwak JY; Kim EK; Yun M; Cho A; Kim MJ; Son EJ; Oh KK
    AJR Am J Roentgenol; 2008 Aug; 191(2):598-603. PubMed ID: 18647938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differentiation of malignant and benign superficial lymph nodes by dual time point 18F-FDG PET].
    Su MG; Fan QP; Tian Y; Li FL; Yang XC; Li L; Fan CZ; Tian R
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):517-20. PubMed ID: 19627018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A risk-adapted approach using US features and FNA results in the management of thyroid incidentalomas identified by 18F-FDG PET.
    Choi JS; Choi Y; Kim EK; Yoon JH; Youk JH; Han KH; Moon HJ; Kang WJ; Kwak JY
    Ultraschall Med; 2014 Feb; 35(1):51-8. PubMed ID: 24458573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
    Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-time point PET/CT with F-18 FDG for the differentiation of malignant and benign bone lesions.
    Tian R; Su M; Tian Y; Li F; Li L; Kuang A; Zeng J
    Skeletal Radiol; 2009 May; 38(5):451-8. PubMed ID: 19205695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can the pathology of a thyroid nodule be determined by positron emission tomography uptake?
    Boeckmann J; Bartel T; Siegel E; Bodenner D; Stack BC
    Otolaryngol Head Neck Surg; 2012 Jun; 146(6):906-12. PubMed ID: 22307576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid incidentalomas discovered on positron emission tomography CT scanning - Malignancy rate and significance of standardised uptake values.
    Brindle R; Mullan D; Yap BK; Gandhi A
    Eur J Surg Oncol; 2014 Nov; 40(11):1528-32. PubMed ID: 24915858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
    Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK
    Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. F18-FDG-PET/CT thyroid incidentalomas: a wide retrospective analysis in three Italian centres on the significance of focal uptake and SUV value.
    Bertagna F; Treglia G; Piccardo A; Giovannini E; Bosio G; Biasiotto G; Bahij el K; Maroldi R; Giubbini R
    Endocrine; 2013 Jun; 43(3):678-85. PubMed ID: 23179777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid incidentalomas in FDG-PET/CT: prevalence and clinical impact.
    Bonabi S; Schmidt F; Broglie MA; Haile SR; Stoeckli SJ
    Eur Arch Otorhinolaryngol; 2012 Dec; 269(12):2555-60. PubMed ID: 22298251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.
    Hashimoto Y; Tsujikawa T; Kondo C; Maki M; Momose M; Nagai A; Ohnuki T; Nishikawa T; Kusakabe K
    J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of multi-modality functional imaging in differentiation between benign and malignant thyroid
    Shi H; Yuan Z; Yang C; Zhang J; Liu C; Sun J; Ye X
    Clin Transl Oncol; 2019 Nov; 21(11):1561-1567. PubMed ID: 30924093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects.
    Kang KW; Kim SK; Kang HS; Lee ES; Sim JS; Lee IG; Jeong SY; Kim SW
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4100-4. PubMed ID: 12970270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.